TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E28.68 EPS (ttm)19.20 Insider Own0.10% Shs Outstand392.00M Perf Week4.74%
Market Cap209.37B Forward P/E22.47 EPS next Y24.52 Insider Trans-14.55% Shs Float390.64M Perf Month-6.84%
Income7.60B PEG3.06 EPS next Q5.00 Inst Own90.70% Short Float0.87% Perf Quarter1.89%
Sales41.12B P/S5.09 EPS this Y21.80% Inst Trans0.29% Short Ratio2.25 Perf Half Y-13.58%
Book/sh104.48 P/B5.27 EPS next Y7.44% ROA9.20% Target Price675.44 Perf Year18.36%
Cash/sh7.63 P/C72.15 EPS next 5Y9.37% ROE19.30% 52W Range438.72 - 672.34 Perf YTD-17.46%
Dividend1.20 P/FCF31.77 EPS past 5Y30.70% ROI10.80% 52W High-16.63% Beta0.84
Dividend %0.22% Quick Ratio1.10 Sales past 5Y16.50% Gross Margin48.40% 52W Low27.77% ATR19.27
Employees130000 Current Ratio1.60 Sales Q/Q19.30% Oper. Margin22.00% RSI (14)53.56 Volatility2.98% 3.22%
OptionableYes Debt/Eq0.81 EPS Q/Q-4.50% Profit Margin18.50% Rel Volume1.61 Prev Close550.74
ShortableYes LT Debt/Eq0.77 EarningsApr 28 BMO Payout5.40% Avg Volume1.51M Price560.55
Recom1.80 SMA203.58% SMA50-0.45% SMA200-4.31% Volume215,966 Change1.78%
Apr-25-22Downgrade Wells Fargo Equal Weight → Underweight $525
Jan-26-22Resumed Barclays Overweight $700
Oct-20-21Upgrade Citigroup Neutral → Buy $620 → $700
Oct-15-21Resumed Cowen Outperform $655 → $696
Aug-05-21Resumed Credit Suisse Outperform $580
Jul-16-21Initiated The Benchmark Company Buy $580
Mar-18-21Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-03-21Initiated Barclays Overweight $525
Jan-08-21Upgrade Credit Suisse Neutral → Outperform $490 → $556
Dec-16-20Downgrade Citigroup Buy → Neutral $550 → $500
Dec-02-20Initiated Goldman Buy $570
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $550
Sep-30-20Initiated Atlantic Equities Overweight $494
Sep-14-20Initiated Morgan Stanley Overweight $485
Aug-20-20Resumed JP Morgan Overweight $460
Jul-15-20Upgrade Cleveland Research Neutral → Buy
Jul-07-20Reiterated Needham Buy $383 → $415
Apr-23-20Reiterated Needham Buy $341 → $383
Jan-31-20Reiterated Needham Buy $331 → $341
Jan-22-20Initiated Credit Suisse Neutral $341
May-19-22 02:16PM  
09:00AM  
May-17-22 02:52PM  
May-13-22 11:06AM  
07:20AM  
May-06-22 08:00AM  
May-05-22 11:55AM  
08:15AM  
08:05AM  
May-04-22 05:31PM  
11:47AM  
Apr-28-22 03:00PM  
12:14PM  
12:08PM  
11:17AM  
09:16AM  
07:15AM  
07:07AM  
06:00AM  
05:55AM  
Apr-27-22 10:52AM  
Apr-22-22 10:13AM  
Apr-21-22 03:01PM  
Apr-20-22 09:05AM  
Apr-19-22 05:50PM  
10:14AM  
Apr-15-22 01:20PM  
07:14AM  
Apr-13-22 05:50PM  
11:52AM  
Apr-12-22 12:43PM  
10:01AM  
Apr-11-22 08:00AM  
Apr-08-22 11:35AM  
Apr-07-22 06:07PM  
09:35AM  
Apr-06-22 09:53AM  
Apr-05-22 05:50PM  
04:05PM  
07:46AM  
Apr-04-22 04:10PM  
Mar-30-22 05:50PM  
11:12AM  
08:44AM  
Mar-25-22 07:00AM  
Mar-24-22 05:50PM  
12:08PM  
11:12AM  
Mar-23-22 10:15AM  
Mar-22-22 12:23PM  
Mar-18-22 10:30AM  
Mar-17-22 05:50PM  
Mar-15-22 06:20AM  
Mar-11-22 05:50PM  
08:45AM  
08:36AM  
Mar-10-22 12:48PM  
12:17PM  
Mar-04-22 11:30AM  
07:45AM  
06:20AM  
Mar-02-22 08:00AM  
Feb-28-22 09:57AM  
07:53AM  
Feb-25-22 10:41AM  
01:00AM  
Feb-24-22 01:32PM  
05:39AM  
Feb-23-22 06:00PM  
05:30PM  
12:58PM  
10:49AM  
10:15AM  
08:57AM  
08:36AM  
08:00AM  
Feb-16-22 06:05AM  
Feb-15-22 01:44PM  
09:44AM  
06:20AM  
Feb-14-22 09:07AM  
Feb-09-22 09:16AM  
Feb-08-22 01:02PM  
10:38AM  
09:38AM  
08:30AM  
Feb-07-22 09:38PM  
09:38PM  
06:05PM  
05:38PM  
01:38PM  
01:38PM  
01:05PM  
08:51AM  
08:00AM  
Feb-04-22 05:38PM  
01:38PM  
09:38AM  
Feb-03-22 05:38PM  
05:38PM  
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASPER MARC NChairman & CEOMay 04Option Exercise129.7710,0001,297,700193,373May 05 06:09 PM
CASPER MARC NChairman & CEOMay 04Sale562.462,1811,226,730183,373May 05 06:10 PM
CASPER MARC NChairman & CEOMay 04Sale548.277,8194,286,905185,554May 05 06:09 PM
CASPER MARC NChairman & CEOMay 03Option Exercise129.7710,0001,297,700193,373May 05 06:09 PM
CASPER MARC NChairman & CEOMay 03Sale547.6110,0005,476,103183,373May 05 06:09 PM
CASPER MARC NChairman & CEOMay 02Option Exercise129.7710,0001,297,700193,373May 04 05:35 PM
Spar Debora LDirectorMay 02Sale544.36200108,872810May 04 05:45 PM
CASPER MARC NChairman & CEOMay 02Sale545.6010,0005,456,029183,373May 04 05:35 PM
Lagarde MichelExecutive Vice President & COOMar 01Sale541.296,1003,301,89015,878Mar 02 04:17 PM
MANZI JIM PDirectorFeb 14Sale563.951,500845,92516,252Feb 15 08:24 PM
Stevenson MarkExecutive Vice President & COODec 01Option Exercise175.4626,9254,724,37486,181Dec 03 04:16 PM
Stevenson MarkExecutive Vice President & COODec 01Sale631.8826,92517,013,31059,256Dec 03 04:16 PM
Williamson StephenSr. VP and CFONov 02Option Exercise129.7722,5502,926,31462,771Nov 03 04:34 PM
Stevenson MarkExecutive Vice President & COONov 02Option Exercise175.4626,9254,724,37486,181Nov 03 04:36 PM
Williamson StephenSr. VP and CFONov 02Sale638.1022,55014,389,04540,221Nov 03 04:34 PM
Stevenson MarkExecutive Vice President & COONov 02Sale638.0326,92517,179,05459,256Nov 03 04:36 PM
Stevenson MarkExecutive Vice President & COONov 01Option Exercise175.4626,9254,724,37486,181Nov 03 04:36 PM
Stevenson MarkExecutive Vice President & COONov 01Sale632.6926,92517,035,09359,256Nov 03 04:36 PM
Holmes Joseph R.VP & Chief Accounting OfficerAug 09Option Exercise198.21759150,4401,372Aug 10 04:18 PM
Holmes Joseph R.VP & Chief Accounting OfficerAug 09Sale542.75759411,948897Aug 10 04:18 PM
CASPER MARC NChairman & CEOAug 05Sale539.9310,0005,399,345189,060Aug 06 04:29 PM
CASPER MARC NChairman & CEOAug 04Sale539.0510,0005,390,468199,060Aug 06 04:29 PM
CASPER MARC NChairman & CEOAug 03Sale535.7310,0005,357,276209,060Aug 04 04:25 PM
Stevenson MarkExecutive Vice President & COOAug 02Option Exercise175.4626,9254,724,37489,279Aug 04 04:22 PM
CASPER MARC NChairman & CEOAug 02Sale535.4610,0005,354,584219,060Aug 04 04:25 PM
Stevenson MarkExecutive Vice President & COOAug 02Sale535.3826,92514,415,22062,354Aug 04 04:22 PM
MANZI JIM PDirectorJul 30Sale536.54572306,89917,752Aug 02 04:05 PM